Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of $1.70, $1.81 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $17.58 million versus the consensus estimate of $8.83 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.